21 CFR § 211.111 Current Good Manufacturing Practice for Finished Pharmaceuticals

§ 211.111 Time limitations on production.

Current through Sep 8, 2026 · Read all of Part 211

When appropriate, time limits for the completion of each phase of production shall be established to assure the quality of the drug product. Deviation from established time limits may be acceptable if such deviation does not compromise the quality of the drug product. Such deviation shall be justified and documented.

← § 211.110 Sampling and testing of in-process materials and drug products.§ 211.113 Control of microbiological contamination. →